Furthermore, recent studies found that BAY 11-7082 is considered an antagonist of causes, not only the activation of NF-kB, but it can also alleviate psoriasis-like dermatitis by inhibiting the NLRP3 inflammasome and the NF-kB pathway [28]. Here, NFKB1 is linked to psoriasis.